Back to Results
First PageMeta Content
Clinical research / Pharmacology / Design of experiments / Evaluation methods / Bioethics / Tiotropium bromide / Placebo-controlled study / Dose-ranging study / Clinical trial / Medicine / Science / Research


CI-1 Spiriva® RESPIMAT® (tiotropium bromide) Inhalation Spray United States Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee
Add to Reading List

Open Document

File Size: 1,70 MB

Share Result on Facebook

Company

Medicine / Regulatory Affairs Boehringer Ingelheim Pharmaceuticals Inc. / Affairs Boehringer Ingelheim Pharmaceuticals / Inc. / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

portfolio products / active device / /

MedicalCondition

stroke / COPD / /

Organization

Inhalation Spray United States Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee / /

/

Position

Vice President / /

Product

Spiriva / RESPIMAT / CI-9 / HandiHaler® / /

SocialTag